News
Regeneron’s stock is having its worst day in 14 years after the failure of late-stage trial of its COPD treatment, after ...
Adoption of generative AI has exceeded even the ambitious strategies set by organizations in 2024. The technology has been ...
1d
Investor's Business Daily on MSNSummit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile FailureSummit Therapeutics stock plunged Friday after its highly watched cancer drug failed to significantly improve overall survival.
Among patients with pulmonary arterial hypertension treated with selexipag, the 10-year survival rate was 60%, according to ...
The Caribbean Examinations Council (CXC) assessments, particularly the Caribbean Secondary Education Certificate (CSEC), ...
Amphenol returns the remainder of its excess capital to shareholders. Amphenol pays a quarterly dividend, and has maintained a dividend payout ratio above 25% since 2019. Amphenol also conducts ...
Analysis: Spokeswoman’s breathless lambast ignores the fact that Trump’s unprecedented usage of executive actions could ...
A UK-based study reveals that patients starting dialysis after transplant kidney failure have higher mortality and are less ...
As President Bola Tinubu marks two years in office today, former Vice President Atiku Abubakar, the Peoples Democratic Party, ...
EMJ spoke with Srihari S. Naidu, who shared insights into his pioneering work in alcohol septal ablation, his contributions ...
The liver is responsible for more than 500 functions in the human body, including filtering harmful substances from the blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results